NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹1,483 Cr | ₹1,139 Cr | ₹921 Cr | ₹761 Cr | ₹581 Cr |
What is the latest Total Current Assets ratio of NEULAND LABORATORIES ?
| Year | Total Current Assets |
|---|---|
| Mar2026 | ₹1,483 Cr |
| Mar2025 | ₹1,139 Cr |
| Mar2024 | ₹921 Cr |
| Mar2023 | ₹761 Cr |
| Mar2022 | ₹581 Cr |
How is Total Current Assets of NEULAND LABORATORIES Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,483 Cr | 30.16 | |
| Mar2025 | ₹1,139 Cr | 23.71 | |
| Mar2024 | ₹921 Cr | 21.05 | |
| Mar2023 | ₹761 Cr | 31.01 | |
| Mar2022 | ₹581 Cr | - | |
Compare Total Current Assets of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹26,726.1 Cr | -4.5% | -12.9% | 38.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -4.5% |
-12.9% |
38.2% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses